Cuu Long Pharmaceutical JSC (HOSE:DCL)

Market Cap	2.72T +75.9%
Revenue (ttm)	1.31T +1.1%
Net Income	-7.32B -63.6%
EPS	-100.48 -62.2%
Shares Out	73.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	448,786
Average Volume	970,156
Open	36,900
Previous Close	36,900
Day's Range	36,750 - 37,500
52-Week Range	20,850 - 62,800
Beta	0.24
RSI	25.29
Earnings Date	Apr 24, 2026

About HOSE:DCL

Cuu Long Pharmaceutical Joint Stock Company produces drugs, chemicals, and medicines in Vietnam. It offers antihistamine, musculoskeletal, dermatology, analgesics and antipyretics, antibiotics, analgesics and anti-inflammatories, respiratory, gastrointestinal, cardiovascular, vitamins and minerals, and nervous medicines, as well as capsules and medical equipment. The company is also involved in retailing drugs, medical devices, and cosmetics, as well as trades in pharmaceuticals and medical equipment. It sells its products to hospitals, pharmac...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 880
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DCL

Financial Performance

In 2025, HOSE:DCL's revenue was 1.32 trillion, an increase of 1.13% compared to the previous year's 1.31 trillion. Earnings were 19.52 billion, a decrease of -62.16%.